FindTrial
Sign In

Randomised control trial to study effect of piroxicam in improving pregnancy rate in intrauterine insemination

Open label randomised control trial to study effect of piroxicam in improving pregnancy rate in intrauterine insemination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051139
Enrollment
100
Registered
2023-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Effect of piroxicam in intrauterine insemination: Piroxicam is an NSAIDS drug which reduces uterine contractility and therefore we will use it in patients with intrauterine insemination

Sponsors

Sadhana Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL FEMALE IN REPRODUCTIVE AGE GROUP UNDERGOING IUI

Exclusion criteria

Exclusion criteria: Hypersensitivity to piroxicam Any Incompletely cured preexisting disease which can affect drug metabolism absorption and distribution and elimination

Design outcomes

Primary

MeasureTime frame
Occurrence of clinical pregnancyTimepoint: 1 year—

Secondary

MeasureTime frame
Occurrence of clinical pregnancyTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactSadhana Singh

KING GEORGEâ??S MEDICAL UNIVERSITY

anjooa@gmail.com9450401972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026